RUO recovery research hub
TB-500: research overview, reported ranges and reconstitution
Educational hub for TB-500 with available vial-size variants, reconstitution resources, reported research ranges, safety limitations and links into the BPC-157 recovery research cluster. The page remains strictly RUO and does not provide human-use instructions.
Short answer
TB-500 is presented as an educational research reference in the Thymosin Beta-4 context. Reported ranges and vial examples support research arithmetic, not a recommended dose.
What is TB-500?
TB-500 is discussed in the research context of Thymosin Beta-4, cell migration, actin regulation, inflammatory signaling and tissue-repair models.
TB-500 and thymosin beta-4
TB-500 is discussed as a research peptide concept linked to thymosin beta-4 biology. That relationship requires careful language because it does not equal approved therapeutic use.
Reported ranges and reconstitution
Variant pages organise concentration math, vial-size examples and reported research ranges so TB-500 formats, calculator inputs and reconstitution resources stay clear.
Safety and evidence limits
Available evidence depends on the study model and does not support treatment promises. This hub links to storage safety, evidence framework and methodology resources for a more responsible review.
Available protocol variants
Choose the exact guide you want to view.
TB-500
TB-500 is a synthetic peptide corresponding to the active region of thymosin beta-4 (Tβ4), studied for tissue repair and anti-inflammatory activity. Research sources report subcutaneous administration of 500 mcg to 1 mg, once daily, increased gradually.
View protocolTB-500
TB-500 is a synthetic peptide corresponding to the active region of thymosin beta-4 (Tβ4), studied for tissue repair and anti-inflammatory activity. Research sources report subcutaneous administration of 500 mcg to 1 mg, once daily, increased gradually.
View protocolTB-500
TB-500 is a synthetic peptide corresponding to the active region of thymosin beta-4 (Tβ4), studied for tissue repair and anti-inflammatory activity. Research sources report subcutaneous administration of 500 mcg to 1 mg, once daily, increased gradually.
View protocolTB-500
TB-500 is a synthetic peptide corresponding to the active region of thymosin beta-4 (Tβ4), studied for tissue repair and anti-inflammatory activity. Research sources report subcutaneous administration of 500 mcg to 1 mg, once daily, increased gradually.
View protocolRelated research resources
Internal links that help readers and search engines understand this peptide topic cluster.
Common questions
Short research-only answers for this topic cluster.
What is TB-500?
TB-500 is discussed in the Thymosin Beta-4 research literature, especially around cell migration and tissue-repair models.
How is TB-500 different from thymosin beta-4?
Thymosin beta-4 is an endogenous protein, while TB-500 is presented here as a research peptide concept requiring separate evaluation, not a therapeutic equivalent.
Is there a recommended dose?
No. The site does not provide a recommended dose. Ranges are shown as reported research context and reconstitution math.
How does it connect to reconstitution math?
TB-500 variant pages and the calculator help explain concentration, mcg per unit and vial-size arithmetic in a research context.
What are the evidence limitations?
Evidence varies by study model and should not be read as treatment guidance or human-use instruction.
References
- Ehrlich HP et al. Ann N Y Acad Sci 2010 — Thymosin beta4 enhances repair by organizing connective tissue and preventing the appearance of myofibroblasts.
View Source - Biçer O et al. Jt Dis Relat Surg 2026 — Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study.
View Source - FASEB Journal — Biological activities of thymosin β4 — identification of the TB-500 fragment
View Source - Journal of Chromatography A — Doping control analysis of TB-500 in biological samples
View Source - J. Investigative Dermatology — Thymosin β4 accelerates wound healing (preclinical model)
View Source - WADA Prohibited List — TB-500 as a prohibited substance in competitive sport
View Source - J. Chromatography B (2024) — Quantification of TB-500 metabolites and activity testing (prodrug hypothesis)
View Source - Goldstein AL et al. Expert Opin Biol Ther 2012 — Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications.
View Source
Educational and laboratory research information only. AllPeptides.eu does not sell peptides and does not provide medical advice or human-use instructions.